Literature DB >> 25655357

Symptom burden and quality of life among women with HER2(+) metastatic breast cancer.

Musa Mayer1, Kathleen Lang, Sara Hurvitz, Deepa Lalla, Victoria Federico, Melissa Brammer, Joseph Menzin, Debu Tripathy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25655357     DOI： 10.1111/tbj.12374

Source DB:  PubMed          Journal:  Breast J        ISSN： 1075-122X            Impact factor:   2.431


× No keyword cloud information.
  3 in total

1.  The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors.

Authors:  Julia Lai-Kwon; Chloe Khoo; Serigne Lo; Donna Milne; Mustafa Mohamed; Jeanette Raleigh; Kortnye Smith; Karolina Lisy; Shahneen Sandhu; Michael Jefford
Journal:  J Cancer Surviv       Date:  2019-06-04       Impact factor: 4.442

2.  Patient-reported outcomes in breast cancer FDA drug labels and review documents.

Authors:  Kyungwan Hong; Kayleigh R Majercak; Ester Villalonga-Olives; Eleanor M Perfetto
Journal:  J Patient Rep Outcomes       Date:  2021-04-21

3.  Effectiveness of a multimodal standard nursing program on health-related quality of life in Chinese mainland female patients with breast cancer: protocol for a single-blind cluster randomized controlled trial.

Authors:  Kaina Zhou; Duolao Wang; Xiaole He; Lanting Huo; Jinghua An; Minjie Li; Wen Wang; Xiaomei Li
Journal:  BMC Cancer       Date:  2016-08-31       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.